GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Net Margin %

PT Indofarma Tbk (ISX:INAF) Net Margin % : -87.30% (As of Sep. 2023)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. PT Indofarma Tbk's Net Income for the three months ended in Sep. 2023 was Rp-71,354 Mil. PT Indofarma Tbk's Revenue for the three months ended in Sep. 2023 was Rp81,737 Mil. Therefore, PT Indofarma Tbk's net margin for the quarter that ended in Sep. 2023 was -87.30%.

The historical rank and industry rank for PT Indofarma Tbk's Net Margin % or its related term are showing as below:

ISX:INAF' s Net Margin % Range Over the Past 10 Years
Min: -63.81   Med: -1.29   Max: 0.59
Current: -63.81


ISX:INAF's Net Margin % is ranked worse than
81.98% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.2 vs ISX:INAF: -63.81

PT Indofarma Tbk Net Margin % Historical Data

The historical data trend for PT Indofarma Tbk's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Net Margin % Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.06 0.59 - -1.29 -37.45

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.93 -102.57 -36.39 -30.15 -87.30

Competitive Comparison of PT Indofarma Tbk's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Net Margin % distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Net Margin % falls into.



PT Indofarma Tbk Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PT Indofarma Tbk's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-428462.954/1144108.231
=-37.45 %

PT Indofarma Tbk's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-71353.854/81736.853
=-87.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Indofarma Tbk  (ISX:INAF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


PT Indofarma Tbk Net Margin % Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines